chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Has not gotten second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 3 years before the date of reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 15-Apr-2022 Reporter's comments: The pharmacist asked if the patient had her first shot of Shingrix 3 years ago and had not gotten her second dose, did she need to redo her first dose. The consent to follow up was given. No further details were provided via web form, submitted all available information. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
This spontaneous report as received from the nurse regarding an unspecified patient of unknown age. There was no information about concurrent condition and historical medication. On an unknown date the patient was vaccinated with 1 dose of improperly stored ZOSTAVAX lot # L006380, expiration date 25-MAY-2016. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
On June 2, 2021 i received my second dose of Pfizer. The next day experienced a migraine. It went away with Tylenol. After that I kept experiencing migraines. On 6/13/2021 I began experiencing chills, fever of 102, and the migraine. Is this normal? It?s about to be two weeks.
Nausea, diarrhea, severe headache, dizziness, arm  & neck pain, weakness, muscle aches, sleepiness, light sensitivity. Symptoms started about 12 hours after vaccine and lasted for 3-5 days.
pt recv vax 25OCT97 & began to tremble all over;pt BP checked & pulse was 120;nurse took pt to ER;
Patient vaccinated on 6/14/05 with Menactra (lot U1639AA).  Culture confirmed meningococcal disease on 9/17/06.  Blood culture was positive for Neisseria meningitidis serogroup C.  2/6/09 ER record for 9/17/06 received with DX:  R shoulder strain, elevated WBCs, vomiting and L hand contusion. Pt presented with c/o R shoulder and hand pain with bruising with no recall of trauma.  Pt reports fever, chills and vomiting the night prior. Had sore throat approx 2 weeks ago,  now resolved. PE (+) for R deltoid pain and bruising of the R hand with tenderness. Tx with abx and D/C. Called back for further tx once (+) blood cx result in. Unable to locate treating MD/facility despite multiple attempts. Case closed.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On unspecified dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 lot# N011491 with expiry date: 04-NOV-2018 and lot# N011867 with expiry date: 08-NOV-2018 (dosing details, anatomical location and route were unknown) for prophylaxis. It was reported that the vaccines were exposed to a temperature range of 31F or colder (31.2F) for 2 hours and 32F to 35F for 356.5 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of the several reports from the same reporter. Sender's Comments: US-009507513-1709USA002052: US-009507513-1709USA000595.
Bilateral hand swelling and tingling. Some feeling of swelling in mouth and lowering of voice. 11/16/09 Medical records received for DOS 11/04/09 Final DX: Allergic reaction. Swollen hands, tingling sensation, feeling of mouth swelling 2hrs s/p vaccine. PE revealed mild hand/finger puffiness.
Within 1 minute of receiving vaccine, patient became unresponsive, collapsed, seized, and experienced apnea and bradycardia. Placed in trendelleburg position, epinephrine given and patient became increasingly aware of surroundings, spoke with his father and heart rate O2 saturations rose, O2 never went below 92%. Note in regards to TD vaccine given above - two prior doses of Tdap vaccine had been given.
Generalized vaccinia, non virulent pustules (erythematous rash on chest, neck, face). Benadryl and Tylenol given.
Diarrhea; fatigue; pale; weak x 2 weeks; then on 10/19/2012 sudden onset tachycardia; chest pain; after alot of testing, dx with autonomic neuropathy that can be triggered by a virus. Continues to have sx of tachycardia, orthostatic hypotension, nausea, wt loss; intermittent chest pain, shortness of breath.
Got a few chicken pox rash around the shot itself; This case was reported by a other health professional via other manufacturer and described the occurrence of chickenpox in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chickenpox. On an unknown date, the outcome of the chickenpox was unknown.   It was unknown if the reporter considered the chickenpox to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, after vaccination with shingrix, the patient got chicken pox rash around the shot but that was pretty normal. For tolerance of flu vaccine, refer case US2021AMR066247.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR066247:Same reporter US-GLAXOSMITHKLINE-US2021AMR066251:Same reporter
Patient was administered the Janssen vaccine 20 hours past the recommended 6-hour time after drawing from the vial. The vial was still stored in the fridge from the day beforehand and was assumed to be the day's lot. Pharmacy intern drew a dose from the vial and only assessed for color and any particulate. Pharmacists on duty were not able to double check the vial used. Patient has not reported any symptoms or adverse effects.
Arm began hurting, itching, burning.  Several days now, tried cortisone, cool rags, Tylenol. Pharmacist that gave shot was excellent, no pain of needle or stinging of vaccine entering arm.  Best shot I've ever had.  And have never had a reaction before!
I have had 2 shots for shots for shingles and I still get shingles!/ suspected vaccination failure; I have had 2 shots for shots for shingles and I still get shingles!; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient got 2 shots for shots for shingles and still get shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
Sedation CHILLS, BODY ACHES, LEGS FEEL HEAVY, SWOLLEN LYMPH NODE IN LEFT ARM Narrative:
At 4pm employee developed chest pain at 6:30 pm developed conjunctivitis, temp 100, chest pain with shortness of breath and weakness in both lower extremities.
new swollen spot appeared, 2 inches long and 1 inch wide; bicep area was warm and inflamed, 1 inch wide and 2 inches long; left arm was sore and uncomfortable; left arm was sore and uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of MYOSITIS (bicep area was warm and inflamed, 1 inch wide and 2 inches long), SWELLING (new swollen spot appeared, 2 inches long and 1 inch wide), LIMB DISCOMFORT (left arm was sore and uncomfortable) and MYALGIA (left arm was sore and uncomfortable) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MESALAMINE for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced LIMB DISCOMFORT (left arm was sore and uncomfortable) and MYALGIA (left arm was sore and uncomfortable). On 02-Feb-2021, the patient experienced MYOSITIS (bicep area was warm and inflamed, 1 inch wide and 2 inches long). On 03-Feb-2021, the patient experienced SWELLING (new swollen spot appeared, 2 inches long and 1 inch wide). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, MYOSITIS (bicep area was warm and inflamed, 1 inch wide and 2 inches long), SWELLING (new swollen spot appeared, 2 inches long and 1 inch wide), LIMB DISCOMFORT (left arm was sore and uncomfortable) and MYALGIA (left arm was sore and uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       On  the night of 02 Feb 2021 patient took diphenhydramine, however by the morning of 03feb2021 the "inflamed area had doubled in size."
Information has been received on 16-JAN-2017 from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was inoculated with ZOSTAVAX (lot# and route unknown) on or about 26-OCT-2012, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-MAY-2017 the patient was treated at a dermatology center for the onset of severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles.  As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Arm pain at injection site on Day 1. Pain in underarm area and front of right shoulder on Day 2. About 10 small white, painless spots and bumps on oral mucosa inside of lips, encircling mouth on Day 3. 1small white patch on top of tongue on Day 4.
Pt developed nausea, paleness, diaphoresis @ time of injection of VARICELLA #2. developed redness, swelling, warmth with tenderness and severe soreness on 8-7-09.
acute heart pain; low blood pressure (80/50); fever; dizziness; nausea; strong headache; This is a spontaneous report from a contactable consumer (the patient). This 40-year-old (non-pregnant) female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 02Apr2021 at 09:00 (at the age of 40-year-old) as single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19 and had tested negative for COVID-19 with the Nasal Swab Real-time PCR tests on 17Oct2020 and again on 02Feb2021. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did have an allergy to eggs and having no other medical history. The patient stated that she is completely healthy. The patient's concomitant medications were not reported. The patient did not receive any medications within 2 weeks of vaccination. On 02Apr2021 at 10:00 AM, the patient experienced strong headache, dizziness, nausea, low blood pressure (80/50), acute heart pain and fever. No treatment was received for the adverse events. The patient had a low blood pressure measured 80/50 mmHg on 02Apr2021. The clinical outcomes of the strong headache, dizziness, nausea, low blood pressure (80/50), acute heart pain and fever were resolved in Apr2021.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
Patient started feeling pain right away at injection site and the redness and swelling moved all the way to her forearm, no fever to her knowledge, had cleared up by the time I spoke to her on 10/2/20.  She took Tylenol for the pain
Stated day after, really sore when reaching behind or above. Went to MD, taking anti-inflammatory, returning on 2 weeks. No structural problem, just inflammation.
17 year old son received the Moderna Vaccine; This spontaneous case was reported by an other caregiver and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old son received the Moderna Vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old son received the Moderna Vaccine). On 08-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old son received the Moderna Vaccine) had resolved. Not Provided          No relevant concomitant medication was reported.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: New event added - Dose 2 administered with no ADRs
sickness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sickness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sickness). At the time of the report, ILLNESS (sickness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  No Treatment information was reported.   This case was linked to MOD-2021-256795 (Patient Link).
Should I be seeking medical attention?   Initially had itching for a few minutes, along with arm pain.  Quickly developed headache on right side of head.  Right side of neck, face, lip, arm, and right upper torso ached and felt tingly, like the feeling you get when a dentist gives you novacaine.  This accompanied dizziness which subsided after 10 minutes.  I was examined at the site and vitals were deemed okay.    Over the course of the day, the headache lessened and the torso lost the numbing feeling.  I had a knot at the injection site which gradually went down when I put heat on it. The only residuals I am feeling 22 hours later is numbness in the lip, and of course, my arm aches.  The numbness is aggravating, and I wonder how long it will last.
Vertigo and GI changes after rota vaccine; significant change in appetite as well; intolerance of feeds. Patient is a 10 week old male here with his mom for concerns about excessive spit ups and not able to sleep or keep anything down since having immunizations. No fever. He has had a swollen belly and asks as if in pain for the past few days.
patient arm was awfully sore; Initial information received on 05-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involves a patient of unknown age and gender whose arm was awfully sore (pain in extremity), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient's arm was awfully sore (pain in extremity) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
The customer just got his first Moderna covid 19 doe #1 around 2:30 pm. About 5 minutes later called me to inform me that he felt dizzy. When I came out he looked at me with his lazy eye and sweat. He did not say anything then his eyes rolled back then fainted. He did not remember the event . I pat him on his shoulder and he was awake right a way. I called 911 but he felt better before the emergency people arrived and they checked him out. He refused to go to the hospital.
Allergic reaction similar to one from food allergy--mild but distressing internal throat swelling and itchiness as well as difficulty swallowing. Started about 15 mins after vaccine, with 1 adult Benadryl pill taken approx. 30 mins after, and a 2nd pill taken 20 mins after that as there was no change. Symptoms ended about 30 mins after the 2nd Benadryl was taken.
Difficulty breathing, chest tightness, coughing, wheezing, increased heart rate.
consulting MD reported 3 deaths which occurred in a particular family over a 5 yr period following 1st DTP vax; autopsy dx SIDS in all 3 pts; 1 of the 3 pts was vaxed @ 50 days of age was found dead in bed 8 days p/vax in 1982;
Pt described an up and in technique for the shingles shot. pt complained of a sore arm 2 months post vaccination
A few days after getting the vaccine, I was dizzy, light-headed, nauseated, short of breath, and had bad chest pains. It has been three weeks and my symptoms have not gotten any better.
Raised, egg-sized, itchy area that appeared several hours after the injection and is still present 8 days later.  Will contact family physician if still present on 9th day.  Arm painful to the touch and upon movement for 2 days.  Headache, achiness also for 2 days
Limited movement and pain of arm that vaccine was administered that continues at present 12/13/2011.
Swelling of the entire arm, redness, area was feeling warmer than usual,  pain in the site of injection, and rest of the arm.  Symptoms started on the evening of 10/22/2019.  As of 10/24/2019 10;25am, swelling is almost gone, no redness can be observed, but patient indicates upper arm still hurts.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. On 10th August 2018, the patient received SHINGRIX. On 10th August 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain and injected limb mobility decreased. On 11th August 2018, the patient experienced fever, back pain and stomach pain. In August 2018, the patient experienced dizziness, tongue disorder, chills, feeling unwell and headache. The patient was treated with TYLENOL and BENADRYL. On an unknown date, the outcome of the injection site pain, injected limb mobility decreased, dizziness, tongue disorder, chills, feeling unwell, fever, back pain, stomach pain and headache were unknown. It was unknown if the reporter considered the injection site pain, injected limb mobility decreased, dizziness, tongue disorder, chills, feeling unwell, fever, back pain, stomach pain and headache to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. On the day before reporting, at morning, the patient received the SHINGRIX in the upper arm and believed that she having some adverse reactions. When the shot was administered the patient had immediate pain in upper arm, to the point that she could not even move arm without pain. The night before reporting, 12 hours after receiving SHINGRIX, the patient experienced dizziness, tongue felt funny, chills, just a general feeling of being out of sorts. The patient took TYLENOL and 2 BENADRYL, which helped the tongue issue. The patient also had chills and 1 day after receiving SHINGRIX, at the morning of date of reporting the patient experienced low grade temperature of 99.9 degree F. One day after receiving SHINGRIX, the patient felt like she had been run over by a truck, stomach felt like someone has punched and back hurts. Also, less than a week after receiving SHINGRIX, the patient experienced headache. The patient still has a headache. The patient was asking that these were common side effects or not and would be honest she was a bit concerned about getting the 2nd dose.
Information has been received from a certified medical assistant concerning a 44 year old female with rheumatoid arthritis, migraine, drug hypersensitivity to codeine and sulfonamide allergy who on 11-JUL-2007 was vaccinated IM into the left deltoid with a 0.5 ml dose of PNEUMOVAX 23 (Lot # 655212/0699U).  Concomitant therapy included HUMIRA, ADDERALL, PREVACID, KLONOPIN, IMITREX and ULTRAM.  On 12-JUL-2007, the patient developed an injection site reaction described as swelling of the left arm, "hard", erythema which extended to the elbow and she also experienced difficulty in lifting he arm.  Treatment included ice and ibuprofen.  The symptoms have resolved.  The medical assistant is requesting a lot check.  This is one of three reports from the as same source.  Additional information has been requested.  A standard lot check investigation was performed.  All in-process quality checks for the lot number in question were satisfactory.  The lot met the requirements of the center and was released.